Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Stem Cells and Development|September 3, 2005
Murine side population cells contain cobblestone area-forming cell activity in mobilized bloodKalindi Parmar, Daniel Burdick, Matthew Ethier, et al.Experimental Hematology|March 20, 2003
Sca+CD34- murine side population cells are highly enriched for primitive stem cellsKalindi Parmar, Calies Sauk-Schubert, Daniel Burdick, et al.Cureus|November 25, 2022
A Novel Trial of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)Arina Madan, Theodore Brown, Sudeshna Ray, et al.Clinical Parkinsonism & Related Disorders|May 14, 2023
Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulationPeter LeWitt, Aaron Ellenbogen, Daniel Burdick, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2010
Second generation 2-pyridyl biphenyl amide inhibitors of the hedgehog pathwayGeorgette M Castanedo, Shumei Wang, Kirk D Robarge, et al.The Lancet. Neurology|December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.Journal of Medicinal Chemistry|October 13, 2015
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case StudyRobert Heald, Krista K Bowman, Marian C Bryan, et al.Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.Annals of Internal Medicine|November 7, 2022
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled TrialMichael Camilleri, Thyagarajan Subramanian, Fernando Pagan, et al.Pageof 1